Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women (Q35636071)

9 August 2017

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

Lynne M Mofenson

11

0 references

Elizabeth Smith

12

object named as

Elizabeth Smith

1 reference

9 August 2017

10

D Heather Watts

1 reference

9 August 2017

Chay Huang Sharon Tan

8

object named as

Sharon Huang

1 reference

9 August 2017

14

Kathleen A Kaiser

1 reference

9 August 2017

1

Jashvant D Unadkat

1 reference

9 August 2017

4

Anita A Mathias

1 reference

9 August 2017

Diane W Wara

2

1 reference

9 August 2017

Michael D Hughes

3

1 reference

9 August 2017

Diane T Holland

5

1 reference

9 August 2017

Mary E Paul

6

1 reference

9 August 2017

James Connor

7

1 reference

9 August 2017

Bach-Yen Nguyen

9

1 reference

9 August 2017

Paul Deutsch

13

1 reference

9 August 2017

Ruth E Tuomala

15

1 reference

9 August 2017

language of work or name

English

0 references

publication date

11 December 2006

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

51

1 reference

9 August 2017

2

1 reference

9 August 2017

783-786

1 reference

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Therapeutic drug monitoring in HIV infection: current status and future directions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Physiologic changes in pregnancy and their effect on drug disposition

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Pharmacokinetics of clorazepate in pregnant and non-pregnant women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoprotein

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797783

Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17158945

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HIV's pharmacokinetics, pharmacodynamics, pharmacogenetics, and pharmacogenomics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17158945

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Preven

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17158945

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00420-06

1 reference

9 August 2017

1 reference

9 August 2017

1 reference